Skip to main navigation Skip to search Skip to main content

Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India-Multicentric, real-world study

  • Deependra Vikram Singh
  • , Aniruddha Agarwal
  • , Anubhav Goyal
  • , Daraius Shroff
  • , Jatinder Singh
  • , Pradeep Kumar
  • , Raja Rami Reddy
  • , Ramesh Venkatesh
  • , Shilpi Narnaware
  • , Shrinivas Joshi
  • , Deependra V. Singh
  • , Ritesh Narula
  • , Aishwarya Joshi
  • , Aniruddha Agarwal
  • , Anubhav Goyal
  • , Charu Gupta
  • , Daraius Shroff
  • , Giridhar Anantharaman
  • , Jatinder Singh
  • , Pradeep Kumar
  • Prashant Bawankule, Raja Rami Reddy, Rajiv Jain, Ramesh Venkatesh, Ruchir Tiwari, Shalini Sugumar, Shashank Rai Gupta, Shilpi Narnaware, Shrinivas Joshi, Somendra P. Choudhary
  • Eye-Q Superspecialty Eye Hospitals Gurugram
  • Cleveland Clinic Abu Dhabi
  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
  • Maastricht University
  • Giridhar Eye Institute
  • Shroff Eye Care
  • The Eye Foundation
  • Sarakshi Netralaya
  • Narayana Nethralaya
  • Army Hospital Research and Referral
  • Retina Department
  • L.V. Prasad Eye Institute India
  • Neoretina Eyecare Institute
  • Save Sight Centre
  • Tewari Eye Centre
  • M. M. Joshi Eye Hospital
  • Complete Eye Care Centre Manish Chamber

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India-Multicentric, real-world study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science